Form 4 Mind Medicine (MindMed) For: Sep 25 Filed by: Barrow Robert
Mind Medicine (MindMed) Inc. - Common Shares (MNMD)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
MNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNMD alerts
High impacting Mind Medicine (MindMed) Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
MNMD
News
- MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceBusiness Wire
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.MarketBeat
- MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety DisorderBusiness Wire
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $23.00 price target on the stock.MarketBeat
- Why Mind Medicine Stock Is Soaring Today [Yahoo! Finance]Yahoo! Finance
MNMD
Earnings
- 11/7/24 - Beat
MNMD
Sec Filings
- 2/5/25 - Form SCHEDULE
- 1/30/25 - Form 8-K
- 1/13/25 - Form 8-K
- MNMD's page on the SEC website